Photomedicine and Laser Surgery Journal Publishes Paper on the Evidence to Support the Efficacy of Intense Pulsed Light Therapy for Dry Eye


Dr. Rolando Toyos has been persistently working to develop and perfect his dry eye treatment utilizing Intense Pulsed Light (IPL) therapy for close to 14 years now. The fruits of his labor are paying off as lasting relief has been provided to his patients and thousands of others around the world; in addition to recognition among his peers through publication in top peer reviewed journals and lectures at Ophthalmology conferences. His latest paper, Intense pulsed light treatment for dry eye disease due to meibomian gland dysfunction; a 3-year retrospective study was published in the January, 2015 edition of Photomedicine Laser Surgery. The study was co-authored by William McGill and Dustin Briscoe.

 

Dry eye disease is a medical condition of the ocular surface system that affects tear production and/or drainage and is typically caused by meibomian gland dysfunction (MGD). It is one of the most common disorders seen in any eye doctor’s office. Patients with dry eye may complain of eye stinging, burning, itching, redness, irritation or discomfort. For many, the laborious regimens of hourly application of artificial tears, frequent hot compresses and eyelid scrubbing offer little relief and impact quality of life, not to mention that vision may be blurred, causing difficulty viewing a computer, watching television, or seeing clearly while driving. Dry eye suffers are desperate, frustrated and searching for treatments that offer longer lasting relief. Dr. Toyos saw this frustration in his practice and made it his life’s work to find a solution.

 

The treatment was accidentally discovered when Toyos was treating rosacea patients in his practice with IPL and noted improvements in dry eye symptoms. He contacted DermaMed Solutions, the company who distributes the Quadra Q4 IPL machine he was using, and over the course of a year developed a treatment protocol and energy settings that offered the correct balance of energy to both heat the meibum for easy expression and target the blood vessels which were inflamed and triggering the overproduction of meibum. IPL therapy targets the fine blood vessels called telangiectasia, and shuts them down, helping relieve the inflammation. Since development, Dr. Toyos has shared his treatment protocol with over 300 doctors around the world, brining needed relief to patients and doctors frustrated by this challenging condition.

 

The premiere journal in laser surgery, Photomedicine and Laser Surgery, has just published Dr. Toyos’ three year retrospective study on intense pulse light for dry eye disease.  The study shows that the technology and treatment protocol that Dr. Toyos developed is an efficacious way to treat dry eye disease caused by Meibomian Gland Dysfunction – the most common cause of dry eye disease. The treatment was 93% effective in improving the signs and symptoms of dry eye disease.  The Diamond Q4 IPL technology is from DermaMed Solutions, located in Lenni, Pennsylvania.

 

According to Dr. Toyos, “The publication of our research is an important step in bringing this incredible procedure to more dry eye disease-sufferers.”



Share this post: